糖尿病
大流行
疾病
医学
发病机制
2019-20冠状病毒爆发
2019年冠状病毒病(COVID-19)
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
免疫学
冠状病毒感染
病毒学
内科学
传染病(医学专业)
内分泌学
爆发
作者
Chandrakala Aluganti Narasimhulu,Dinender K. Singla
出处
期刊:American Journal of Physiology-heart and Circulatory Physiology
[American Physiological Society]
日期:2022-07-01
卷期号:323 (3): H403-H420
被引量:44
标识
DOI:10.1152/ajpheart.00204.2022
摘要
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, is a global pandemic impacting 254 million people in 190 countries. Comorbidities, particularly cardiovascular disease, diabetes, and hypertension, increase the risk of infection and poor outcomes. SARS-CoV-2 enters host cells through the angiotensin-converting enzyme-2 receptor, generating inflammation and cytokine storm, often resulting in multiorgan failure. The mechanisms and effects of COVID-19 on patients with high-risk diabetes are not yet completely understood. In this review, we discuss the variety of coronaviruses, structure of SARS-CoV-2, mutations in SARS-CoV-2 spike proteins, receptors associated with viral host entry, and disease progression. Furthermore, we focus on possible mechanisms of SARS-CoV-2 in diabetes, leading to inflammation and heart failure. Finally, we discuss existing therapeutic approaches, unanswered questions, and future directions. Listen to this article’s corresponding podcast at https://ajpheart.podbean.com/e/covid-19-and-diabetes/ .
科研通智能强力驱动
Strongly Powered by AbleSci AI